Company profile: zPredicta
1.1 - Company Overview
Company description
- Provider of bio-simulation technology that combines biology with automation and computation to automate drug development; its platform enables pharma to rapidly identify drug candidates effective in patients; offers r-Organ, a set of next generation 3D culture models.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to zPredicta
Andor
HQ: United Kingdom
Website
- Description: Provider of scientific imaging equipment, designing and manufacturing high-performance cameras (EMCCD, CCD, sCMOS), integrated multimodal confocal microscopy systems for life sciences, spectroscopy platforms based on Czerny-Turner or Echelle spectrometers with advanced detectors, optical cryostats (<3 K to 500 K), photostimulation tools, and imaging/analysis software for scientific research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Andor company profile →
ProZyme
HQ: United States
Website
- Description: Provider of value-added reagents, kits, and platforms for improved analytical results, utilizing microbial fermentation sciences, large-scale native and recombinant purification and formulation, and assay development; also offers analytical services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ProZyme company profile →
Avalyn Pharma
HQ: United States
Website
- Description: Provider of inhaled therapies for idiopathic pulmonary fibrosis and other respiratory diseases, advancing direct-lung delivery candidates including AP01 (Phase 2b-ready inhaled pirfenidone), AP02 (reformulated inhaled nintedanib; Phase 1a completed), AP02-DP (dry powder nintedanib with equivalent pulmonary bioavailability), AP03 (fixed-dose inhaled pirfenidone+nintedanib), and AP04 (inhaled imatinib for PAH).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Avalyn Pharma company profile →
Nanoplex Technologies
HQ: United States
Website
- Description: Provider of nanoparticle-based products for life science research, enabling ultra-sensitive molecular identification and quantitation, as well as authentication and tracking applications; focused on rapidly translating state-of-the-art nanoscience into practical, valuable products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nanoplex Technologies company profile →
Dow Pharmaceutical Sciences
HQ: United States
Website
- Description: Provider of topical drug product development services for pharmaceutical and biotechnology clients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dow Pharmaceutical Sciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for zPredicta
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to zPredicta
2.2 - Growth funds investing in similar companies to zPredicta
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for zPredicta
4.2 - Public trading comparable groups for zPredicta
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →